Navigation Links
Endocare and Galil Medical Sign Definitive Merger Agreement
Date:11/10/2008

luding prostate cancer and kidney tumors. Data now available, using the latest generation of technologies, demonstrate that cryoablation, a non-surgical treatment that often requires no hospital stay, can be just as effective as more invasive, more costly, and more time-consuming options such as radiation and surgery."

The merger and related transactions are expected to create significant clinical and operational advantages for the combined company, allowing it to accelerate technological innovation and promote the growing recognition of cryoablation in the global healthcare marketplace. The combined company will be able to more efficiently promote cryoablation as a safe and effective treatment for a variety of cancers including prostate cancer, the most commonly diagnosed cancer among men. In the U.S. alone, more than 186,000 men are diagnosed with prostate cancer annually according to American Cancer Society estimates.

Emerson continued, "This merger allows the two companies to come together as one to combine the very best in cryoablation technologies, and to jointly demonstrate the clinical and economic advantages cryoablation has over radiation, radical prostatectomy and IMRT in the treatment of prostate cancer as well as in other oncology treatments where cryoablation has application. The company will be much stronger financially following the combination and in a much better position to deliver the promise that cryoablation offers to physicians and patients all over the world."

Rodriguez commented, "This combination has the potential to eliminate millions of dollars in redundant costs and we believe that annualized cost savings of over $10 million could be realized by mid-2010. We expect that this transaction will result in positive adjusted EBITDA within 18 months after the close of the transaction."

Terms of the Merger

The terms of the definitive merger agreement call for a stock-for-stock merger transaction and a concurren
'/>"/>

SOURCE Endocare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Endocare Stock to Commence Trading on NASDAQ
2. Endocare Reports 2007 Third Quarter and Nine-Month Results
3. Endocare Announces That National Cancer Institute to Sponsor Study Comparing Cryoablation to Radiation Therapy for Pain Relief in Bone Cancer Patients
4. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
5. Endocare to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
6. Endocare Reports Financial Results for Second Quarter 2008
7. Endocare Comments on Unsolicited Proposal
8. Endocare and Former CFO Agree to Terminate Indemnification Agreement
9. Endocare to Present at Oppenheimer 19th Annual Healthcare Conference
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 A leading proposal to temporarily ... trust fund by reallocating payroll taxes has virtually no ... The Senior Citizens League (TSCL) . Less ... from the Social Security retirement trust fund to pay ... disability program’s financing. “TSCL believes this ‘band aid’ approach ...
(Date:7/28/2014)... The “Tissue Diagnostics Market by ... & Workflow, Special Staining), Disease (Breast Cancer, ... Cell Lung Cancer and Others), Product (Instruments ... Laboratories, Contract Research Organizations and Others) & ... & RoW) - Trends & Forecast to ...
(Date:7/28/2014)... A January 2013 study published ... in those who were self-diagnosed gluten-intolerant yielded little verifiable ... for San Diego health and wellness retreat VeraVia ... those who are unclear about the role gluten plays ... a protein, found in wheat, barley, rye, and triticale. ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, ... milliseconds to look at someone,s face and judge them good-looking ... certain facial features seem to trigger specific first impressions about ... the mouth, for example, appear directly linked to whether someone ... The study findings suggest that first impressions are fairly ...
(Date:7/28/2014)... Shofner Vision Center recently wrapped ... Renowned LASIK and Cataract Surgeon, Dr. Stewart Shofner ... and public awareness for local not-for-profit organizations that ... their families. “This was our 2nd annual summer ... to a variety of local not-for-profit organizations who ...
Breaking Medicine News(10 mins):Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 2Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 3Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3
... CHICAGO Jorge Sobenes is a husband and father who loves ... he went from enjoying his favorite foods to not being able ... and difficulty swallowing. He lost 40 pounds and was desperate ... the esophagus is unable to move food into the stomach, and ...
... with hepatocellular carcinoma (HCC) is achievable using 90Y-resin ... across Europe showed that the procedure is likely ... including patients with advanced liver cancer and with ... to dateare published in the September issue of ...
... -- An experimental drug that,s shown promise against ovarian cancer ... also be effective against ovarian cancer not caused by those ... the activity of a protein called poly ADP ribose polymerase ... repair. Clinical trials of olaparib in patients with BRCA 1 ...
... HealthDay Reporter , MONDAY, Aug. 22 (HealthDay News) -- ... also appears linked to a decline in mammograms, new research ... 50 to 64 reduced their hormone therapy use from 41 ... study lead author Nancy Breen, an economist with the U.S. ...
... can act as "weight shocks," leading people to add a few ... to a new study. But when it comes to large ... men than they are for women. For men, the risk ... But for women, the risk of a large weight gain was ...
... HealthDay Reporter , SATURDAY, Aug. 20 (HealthDay News) -- Working ... stay-at-home moms, a new study finds. However, working moms ... about how easy it will be to balance work and ... counterparts. , , Researchers analyzed survey results from 1,600 married ...
Cached Medicine News:Health News:Incisionless surgery now available as an investigational treatment for esophageal disorder 2Health News:Radioembolization improves chance of survival for liver cancer patients 2Health News:Trial Drug Shows Preliminary Promise Against Ovarian Cancer 2Health News:Decline in Hormone Therapy Linked to Fewer Mammograms 2Health News:Large weight gains most likely for men after divorce, women after marriage 2Health News:Large weight gains most likely for men after divorce, women after marriage 3Health News:Trying to Be 'Supermom' Can Raise Risk for Depression 2Health News:Trying to Be 'Supermom' Can Raise Risk for Depression 3
(Date:7/29/2014)... , July 29, 2014   ... II study investigating the efficacy and safety of MSB0010718C in ... is a rare and aggressive skin cancer lacking effective treatments   ... seven cohort Phase I clinical trial for the treatment of ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
This is adapted to microplate or card....
Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... cell accommodates up to 12 large slab ... in the PROTEAN IEF system, for high-throughput ... PROTEAN Plus Dodeca cell's cooling and recirculating ... consistent, high-resolution results. The handcasting system includes ...
Medicine Products: